Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Vice President Pharmaceutical Sciences & Technology at Visterra Inc.
Dr. rer. nat Jorg Thommes is the Senior Vice President Pharmaceutical Sciences and Technology at Visterra. In this role he is responsible for all aspects of CMC development, manufacturing, and drug supply for Visterra’s products. Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope® platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines against such targets that are not adequately addressed with conventional approaches. Prior to joining Visterra, Dr. Thommes was at Biogen, Inc., where he served among other positions as Senior Vice President, Engineering and Technology, and his responsibilities included process development for all therapeutic modalities, global and site engineering, and manufacturing sciences. Previously, Dr. Thommes was the Director, Protein Purification Development, at IDEC Pharmaceuticals and prior to IDEC, he held a research and teaching position at the Institute of Enzyme Technology at University of Dusseldorf, Germany. He serves on the board of the Recovery of Biological Products conference series and was chairman of that board from 2014 to 2016. Dr. Thommes received a Diplom-Chemiker degree from University of Bonn, Germany, a Doctorate of Natural Sciences from University of Bonn, Germany, and a Habilitation Degree in Biochemical Engineering from University of Dusseldorf, Germany.